Xentria Inc. A Technology Powerhouse Driving Change

Xentria ... Focused on becoming a critical leader in the biopharma industry through a strong portfolio of products having purpose for patients. Driven to treat ... Sponsor: Xentria, Inc. Overall Status: Active - Recruiting. Phase. 1/2. Condition. Sarcoidosis. Lung Disease. Treatment. XTMAB-16 or Placebo ... Xentria, Inc. has partnered with the Foundation for Sarcoidosis Research for the XTMAB16 Study. XTMAB-16 is a tumor necrosis factor (TNF) inhibitor that aims to ... Xentria, Inc. (Xentria), a clinical-stage biotherapeutics company focused on advancing drug development to address unmet medical needs ... Xentria, Inc. Jessica Reeves' profile picture. logo. Jessica Reeves. Leukaemia Foundation. Company. AboutSupportTrust. Resources. IterateCompanies. Platform. Xentria Inc. has recently announced they received Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for their ... Prior to this appointment, Dr Sacco held Vice President and Head of Clinical Development roles at Xentria, Inc. and AnaptysBio, Inc., overseeing ... CHICAGO, IL June 27, 2023: Xentria Inc., a clinical-stage biotherapeutics company focused on developing therapeutics to address unmet clinical needs, ... 09, 2023 (GLOBE NEWSWIRE) — Imbria Pharmaceuticals, Inc., a clinical stage, cardiometabolic company developing novel therapies designed to ... Ensayos clínicos para Xentria, Inc.. Registro de ensayos clínicos. ICH GCP.